Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today

OMAHA, Neb.--()--Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:

   
What: Transgenomic, Inc. First Quarter 2014 Financial Results and Business Update Conference Call
 
When: Wednesday, May 7, 2014 @ 5:00 p.m. Eastern
 
Where:

http://www.videonewswire.com/event.asp?id=99172

 
How: Live over the Internet -- Simply log on to the web at the address above.
 
Contact: Investor Relations, 402-452-5416
 

To access the call via telephone, dial 866-952-1907 from the U.S. and Canada or 785-424-1826 for international participants and enter conference ID TRANS. A telephone replay will be available from 8:00 p.m. Eastern Time on May 7, 2014 through 11:59 p.m. Eastern Time on May 21, 2014 by dialing 800-839-3020 (domestic) or 402-220-7234 (international).

About Transgenomic, Inc.

Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases. The Company has three complementary business units: Patient Testing, Biomarker Identification, and Genetic Assays and Platforms, which provide specialized diagnostic tests, contract research services for drug development, and equipment, reagents and other consumables for clinical and research applications in molecular testing and cytogenetics.

Contacts

Investor Contact
Argot Partners
Susan Kim, 212-600-1902
susan@argopartners.com
or
Media Contact
BLL Partners LLC
Barbara Lindheim, 212-584-2276
blindheim@bllbiopartners.com
or
Company Contact
Transgenomic, Inc.
Donna Christian, 402-452-5416
investorrelations@transgenomic.com

Sharing

Contacts

Investor Contact
Argot Partners
Susan Kim, 212-600-1902
susan@argopartners.com
or
Media Contact
BLL Partners LLC
Barbara Lindheim, 212-584-2276
blindheim@bllbiopartners.com
or
Company Contact
Transgenomic, Inc.
Donna Christian, 402-452-5416
investorrelations@transgenomic.com